Search Results for: International Stem Cell Corporation to
Articles
December 11, 2011
12/13/2011 December 11, 2011
Abbott Laboratories Spends $400 Million on Development Deal Abbott Laboratories and Reata Pharmaceuticals recently announced they have entered into a worldwide...
November 20, 2011
11/22/2011 November 20, 2011
Apricus Biosciences Announces NexACT Partner Has Completed pre-IND Meeting Apricus Biosciences, Inc. recently announced its NexACT out-licensing partner, Exodos Life...
November 10, 2011
11/15/2011 November 10, 2011
Lundbeck & Otsuka Enter Long-Term CNS Agreement, Deal Has $1.8-Billion Potential Otsuka Pharmaceutical Co., Ltd. and H. Lundbeck A/S recently...
November 10, 2011
Accentia Biopharmaceuticals to Sell Analytica for $10 Million November 10, 2011
Accentia Biopharmaceuticals, Inc. recently announced it has entered into a series of agreements to strengthen its financial position, improve its...
October 20, 2011
10/25/2011 October 20, 2011
Abbott to Separate Into Two Leading Companies Abbott recently announced it plans to separate into two publicly traded companies, one...
September 1, 2011
9/6/2011 September 1, 2011
Jennerex's Virus-Based Drug Targets & Infects Tumors Jennerex, Inc. recently announced the publication of clinical data on its lead product...
September 1, 2011
Jennerex's Virus-Based Drug Targets & Infects Tumors September 1, 2011
Jennerex, Inc. recently announced the publication of clinical data on its lead product JX-594. For the first time in humans,...
August 18, 2011
8/23/2011 August 18, 2011
Intellipharmaceutics & Par Pharmaceutical Expand Development & Commercialization Agreement Intellipharmaceutics International Inc. recently announced that they have added the development...
August 11, 2011
8/16/2011 August 11, 2011
Boehringer Ingelheim Licenses ProBioGen's GlymaxX Technology Boehringer Ingelheim and ProBioGen AG recently announced they have signed a non-exclusive Licensing...
July 19, 2011
7/26/2011 July 19, 2011
Daiichi Sankyo Launches Direct Oral Factor Xa Inhibitor Daiichi Sankyo Company, Limited recently announced the launch of LIXIANA (JAN: Edoxaban...
June 15, 2011
6/21/2011 June 15, 2011
Tekmira's LNP Delivery Technology Enables Proof of RNAi in Man & Clinical Activity Tekmira Pharmaceuticals Corporation recently provided comments...
March 13, 2011
3/15/2011 March 13, 2011
Cytheris Announces Study Results Indicating CYT107 Expands CD4 T-Cells Cytheris SA, a clinical-stage biopharmaceutical company focused on research and development...
February 27, 2011